难治性-话题@MedSci

#难治性#

683篇内容 | 2671人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528860, encodeId=3c9d1528860b2, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=BJH：单独使用纳武利尤单抗可以治愈复发或难治性霍奇金淋巴瘤患者吗？法国早期访问计划 (EPA) 的 5 年分析, objectType=article, longId=725441, objectId=02cce25441be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02cce25441be, replyNumber=0, likeNumber=82, createdTime=2022-04-27, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02cce25441be, moduleTitle=BJH：单独使用纳武利尤单抗可以治愈复发或难治性霍奇金淋巴瘤患者吗？法国早期访问计划 (EPA) 的 5 年分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02cce25441be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528864, encodeId=8a72152886415, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Neurology：皮下长期心脏监测仪有助于检测难治性癫痫患者的严重心律失常！, objectType=article, longId=724898, objectId=e594e2489846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e594e2489846, replyNumber=0, likeNumber=56, createdTime=2022-04-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e594e2489846, moduleTitle=Neurology：皮下长期心脏监测仪有助于检测难治性癫痫患者的严重心律失常！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e594e2489846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528859, encodeId=00dc15288594b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=PA3-17注射液治疗成人复发/难治性CD7阳性血液淋巴系统恶性肿瘤患者的I期临床研究, objectType=article, longId=724803, objectId=de5ee24803e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de5ee24803e5, replyNumber=0, likeNumber=104, createdTime=2022-04-24, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de5ee24803e5, moduleTitle=PA3-17注射液治疗成人复发/难治性CD7阳性血液淋巴系统恶性肿瘤患者的I期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de5ee24803e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528858, encodeId=897615288585a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, objectType=article, longId=724745, objectId=639fe24745ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639fe24745ff, replyNumber=0, likeNumber=42, createdTime=2022-04-23, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639fe24745ff, moduleTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639fe24745ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528857, encodeId=c292152885ef8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JEADV：难治性银屑病的患病率和特征以及对生物治疗的超级反应, objectType=article, longId=724105, objectId=0b70e24105f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b70e24105f0, replyNumber=0, likeNumber=67, createdTime=2022-04-13, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b70e24105f0, moduleTitle=JEADV：难治性银屑病的患病率和特征以及对生物治疗的超级反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b70e24105f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528856, encodeId=fe2e152885658, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Leukemia：自体或异体造血细胞移植治疗复发或难治性 PTCL-NOS 或 AITL生存结果的比较, objectType=article, longId=723599, objectId=f956e235993f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f956e235993f, replyNumber=0, likeNumber=64, createdTime=2022-04-07, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f956e235993f, moduleTitle=Leukemia：自体或异体造血细胞移植治疗复发或难治性 PTCL-NOS 或 AITL生存结果的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f956e235993f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528855, encodeId=80f71528855ff, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Leukemia：口服沙利度胺-环磷酰胺-地塞米松治疗复发/难治性成人朗格汉斯细胞组织细胞增多症是有效且安全的方案, objectType=article, longId=723518, objectId=20a9e235180d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20a9e235180d, replyNumber=0, likeNumber=81, createdTime=2022-04-06, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20a9e235180d, moduleTitle=Leukemia：口服沙利度胺-环磷酰胺-地塞米松治疗复发/难治性成人朗格汉斯细胞组织细胞增多症是有效且安全的方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20a9e235180d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528854, encodeId=7df8152885418, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Front Oncol：国内多中心评估Regorafenib（瑞戈非尼）三线或以上治疗难治性转移性结直肠癌（mCRC）患者的疗效, objectType=article, longId=723399, objectId=0052e23399a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0052e23399a4, replyNumber=0, likeNumber=109, createdTime=2022-04-05, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0052e23399a4, moduleTitle=Front Oncol：国内多中心评估Regorafenib（瑞戈非尼）三线或以上治疗难治性转移性结直肠癌（mCRC）患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0052e23399a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528853, encodeId=2a72152885368, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAMA Cardiol：采用经皮心肌内室间隔射频消融术治疗难治性肥厚型梗阻性心肌病的预后和安全性, objectType=article, longId=302265, objectId=10de3022656b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10de3022656b, replyNumber=0, likeNumber=80, createdTime=2022-04-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10de3022656b, moduleTitle=JAMA Cardiol：采用经皮心肌内室间隔射频消融术治疗难治性肥厚型梗阻性心肌病的预后和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10de3022656b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528852, encodeId=956d152885269, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：泽布替尼治疗复发/难治性套细胞淋巴瘤的长期疗效, objectType=article, longId=301380, objectId=19cc301380e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19cc301380e9, replyNumber=0, likeNumber=86, createdTime=2022-03-23, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19cc301380e9, moduleTitle=Blood：泽布替尼治疗复发/难治性套细胞淋巴瘤的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19cc301380e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528851, encodeId=0225152885128, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=PPM：他克莫司剂量/体重调整谷值预测儿童难治性肾病综合征, objectType=article, longId=301231, objectId=fd2330123165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd2330123165, replyNumber=0, likeNumber=0, createdTime=2022-03-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd2330123165, moduleTitle=PPM：他克莫司剂量/体重调整谷值预测儿童难治性肾病综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd2330123165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528850, encodeId=edb3152885084, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Clin Hypertens：沙库巴曲缬沙坦ARNI治疗亚洲人群难治性高血压结果发布, objectType=article, longId=301099, objectId=19ad30109965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ad30109965, replyNumber=0, likeNumber=93, createdTime=2022-03-20, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ad30109965, moduleTitle=J Clin Hypertens：沙库巴曲缬沙坦ARNI治疗亚洲人群难治性高血压结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ad30109965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528849, encodeId=c09415288491a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=“脑机接口”新突破！难治性癫痫患者迎来曙光, objectType=article, longId=301002, objectId=0384301002a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0384301002a6, replyNumber=0, likeNumber=109, createdTime=2022-03-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0384301002a6, moduleTitle=“脑机接口”新突破！难治性癫痫患者迎来曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0384301002a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528848, encodeId=0bc51528848d4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=BMC Cancer：中肿团队HER2阳性难治性转移性乳腺癌转化模式疗法疗效显著, objectType=article, longId=300955, objectId=f42b30095557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f42b30095557, replyNumber=0, likeNumber=92, createdTime=2022-03-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f42b30095557, moduleTitle=BMC Cancer：中肿团队HER2阳性难治性转移性乳腺癌转化模式疗法疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f42b30095557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528847, encodeId=2333152884e00, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Oncologist：西妥昔单抗+伊立替康+贝伐单抗联合治疗未能改善伊立替康难治性转移性结直肠癌(mCRC)的患者PFS，但可改善OS, objectType=article, longId=300705, objectId=242e300e0568, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=242e300e0568, replyNumber=0, likeNumber=41, createdTime=2022-03-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=242e300e0568, moduleTitle=Oncologist：西妥昔单抗+伊立替康+贝伐单抗联合治疗未能改善伊立替康难治性转移性结直肠癌(mCRC)的患者PFS，但可改善OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=242e300e0568)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528846, encodeId=583b1528846a6, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Acta Haematol：化疗或同种异体干细胞移植作为难治性急性髓细胞白血病患者的抢救疗法的影响, objectType=article, longId=300555, objectId=c2d0300555d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2d0300555d0, replyNumber=0, likeNumber=96, createdTime=2022-03-13, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2d0300555d0, moduleTitle=Acta Haematol：化疗或同种异体干细胞移植作为难治性急性髓细胞白血病患者的抢救疗法的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2d0300555d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528845, encodeId=8311152884570, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=李悦：如何处理冠状动脉难治性血栓, objectType=article, longId=300348, objectId=e86b3003484c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e86b3003484c, replyNumber=0, likeNumber=0, createdTime=2022-03-10, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e86b3003484c, moduleTitle=李悦：如何处理冠状动脉难治性血栓, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e86b3003484c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528898, encodeId=9f7a1528898c0, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=AJH：地西他滨和伏立诺他联合 FLAG 化疗治疗儿科复发/难治性 AML：儿童白血病和淋巴瘤 (TACL) 联盟的治疗进展报告, objectType=article, longId=300245, objectId=d19a300245bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d19a300245bc, replyNumber=0, likeNumber=118, createdTime=2022-03-09, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d19a300245bc, moduleTitle=AJH：地西他滨和伏立诺他联合 FLAG 化疗治疗儿科复发/难治性 AML：儿童白血病和淋巴瘤 (TACL) 联盟的治疗进展报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d19a300245bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528844, encodeId=7570152884491, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAMA：集束化措施对难治性院外心脏骤停的疗效, objectType=article, longId=300057, objectId=2f0530005e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0530005e2c, replyNumber=0, likeNumber=0, createdTime=2022-03-06, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0530005e2c, moduleTitle=JAMA：集束化措施对难治性院外心脏骤停的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0530005e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528843, encodeId=613215288438b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：FLT3抑制剂Gilteritinib vs 挽救化疗对复发/难治性AML患者长期预后的影响, objectType=article, longId=299714, objectId=365f299e146f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=365f299e146f, replyNumber=0, likeNumber=94, createdTime=2022-02-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=365f299e146f, moduleTitle=Blood：FLT3抑制剂Gilteritinib vs 挽救化疗对复发/难治性AML患者长期预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=365f299e146f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

BJH：单独使用纳武利尤单抗可以治愈复发或难治性霍奇金淋巴瘤患者吗？法国早期访问计划 (EPA) 的 5 年分析

2022-04-27

freve (审核中...)

前往app查看评论内容

#难治性#

Neurology：皮下长期心脏监测仪有助于检测难治性癫痫患者的严重心律失常！

2022-04-25

freve (审核中...)

前往app查看评论内容

#难治性#

PA3-17注射液治疗成人复发/难治性CD7阳性血液淋巴系统恶性肿瘤患者的I期临床研究

2022-04-24

freve (审核中...)

前往app查看评论内容

#难治性#

药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批

2022-04-23

freve (审核中...)

前往app查看评论内容

#难治性#

JEADV：难治性银屑病的患病率和特征以及对生物治疗的超级反应

2022-04-13

freve (审核中...)

前往app查看评论内容

#难治性#

Leukemia：自体或异体造血细胞移植治疗复发或难治性 PTCL-NOS 或 AITL生存结果的比较

2022-04-07

freve (审核中...)

前往app查看评论内容

#难治性#

Leukemia：口服沙利度胺-环磷酰胺-地塞米松治疗复发/难治性成人朗格汉斯细胞组织细胞增多症是有效且安全的方案

2022-04-06

freve (审核中...)

前往app查看评论内容

#难治性#

Front Oncol：国内多中心评估Regorafenib（瑞戈非尼）三线或以上治疗难治性转移性结直肠癌（mCRC）患者的疗效

2022-04-05

freve (审核中...)

前往app查看评论内容

#难治性#

JAMA Cardiol：采用经皮心肌内室间隔射频消融术治疗难治性肥厚型梗阻性心肌病的预后和安全性

2022-04-04

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：泽布替尼治疗复发/难治性套细胞淋巴瘤的长期疗效

2022-03-23

freve (审核中...)

前往app查看评论内容

#难治性#

PPM：他克莫司剂量/体重调整谷值预测儿童难治性肾病综合征

2022-03-21

freve (审核中...)

前往app查看评论内容

#难治性#

J Clin Hypertens：沙库巴曲缬沙坦ARNI治疗亚洲人群难治性高血压结果发布

2022-03-20

freve (审核中...)

前往app查看评论内容

#难治性#

“脑机接口”新突破！难治性癫痫患者迎来曙光

2022-03-18

freve (审核中...)

前往app查看评论内容

#难治性#

BMC Cancer：中肿团队HER2阳性难治性转移性乳腺癌转化模式疗法疗效显著

2022-03-18

freve (审核中...)

前往app查看评论内容

#难治性#

Oncologist：西妥昔单抗+伊立替康+贝伐单抗联合治疗未能改善伊立替康难治性转移性结直肠癌(mCRC)的患者PFS，但可改善OS

2022-03-15

freve (审核中...)

前往app查看评论内容

#难治性#

Acta Haematol：化疗或同种异体干细胞移植作为难治性急性髓细胞白血病患者的抢救疗法的影响

2022-03-13

freve (审核中...)

前往app查看评论内容

#难治性#

李悦：如何处理冠状动脉难治性血栓

2022-03-10

freve (审核中...)

前往app查看评论内容

#难治性#

AJH：地西他滨和伏立诺他联合 FLAG 化疗治疗儿科复发/难治性 AML：儿童白血病和淋巴瘤 (TACL) 联盟的治疗进展报告

2022-03-09

freve (审核中...)

前往app查看评论内容

#难治性#

JAMA：集束化措施对难治性院外心脏骤停的疗效

2022-03-06

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：FLT3抑制剂Gilteritinib vs 挽救化疗对复发/难治性AML患者长期预后的影响

2022-02-28

科室
- - 订阅+
  - 更多科室
工具
服务